Chemical Compound
(3S)-3-amino-4-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
CAS Registry Number
135306-85-3
Primary record
(3S)-3-amino-4-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
- 库存
- 4,363 克
- 纯度
- 98.7 %
- CAS
- 135306-85-3
化合物标识与属性
- CAS
- 135306-85-3
- PubChem CID
- 124003
- SMILES
- CC(C)[C@@H](C(=O)N[C@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CC=C(C=C7)O)NC(=O)[C@H](CC(=O)O)N
- Canonical SMILES
- CC(C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
名称与同义词
- Men 10376
- 135306-85-3
- AC1L3XPV
- RefChem:156452
- CHEMBL507824
- MEN-10,376
- GTPL2116
- orb1706996
- MEN10376
- Neurokinin-2 receptor antagonist
- MEN-10376
- MFCD00144736
- DTXSID001365500
- HY-P1276
- BDBM50259674
- C57H68N12O10
- CID124003
- AKOS030623006
- neurokinin A(4-10), Tyr(5)-Trp(6,8,9)-Lys(10)-
- BAT-010261
- C57-H68-N12-O10
- NCGC00167321-01
- DA-48909
- MS-33182
- 5-Tyr-6,8,9-trp-10-lys-neurokinin A (4-10)
- J776.603C
- CS-0029214
- Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Lys-NH(2)
- H-Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Lys-NH2
- ASP-TYR-D-TRP-VAL-D-TRP-D-TRP-LYS-NH2
- [Tyr5,D-Trp6,8,9,Lys10]neurokinin A(4-10)
- (3S)-3-amino-4-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
- A1128055
- L-Asp-L-Tyr-D-Trp-L-Val-D-Trp-D-Trp-L-Lys-NH2
- Neurokinin A(4-10), tyrosyl(5)-tryptophyl(6,8,9)-lysine(10)-
- Q27084374
- (Tyr5,D-Trp6.8.9,Lys-NH21?)-Neurokinin A (4-10)
- (Tyr5,D-Trp6.8.9,Lys-NH210)-Neurokinin A (4-10)
- (Tyr5,D-Trp6?8?9,Lys-NH210)-Neurokinin A (4-10)
- [Tyr5,D-Trp6,8,9,Lys10]-alpha-NEUROKININ A, Fragment 4-10
- (3S)-3-amino-3-{[(1S)-1-{[(1R)-1-{[(1S)-1-{[(1R)-1-{[(1R)-1-{[(1S)-5-amino-1-carbamoylpentyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid
- L-Lysinamide, L-alpha-aspartyl-L-tyrosyl-D-tryptophyl-L-valyl-D-tryptophyl-D-tryptophyl-
- L-Lysinamide, L-I+/--aspartyl-L-tyrosyl-D-tryptophyl-L-valyl-D-tryptophyl-D-tryptophyl-
- L-Lysinamide,l-a-aspartyl-l-tyrosyl-D-tryptophyl-L-valyl-D-tryptophyl-D-tryptophyl-
- (3S)-3-amino-4-(((2S)-1-(((2R)-1-(((2S)-1-(((2R)-1-(((2R)-1-(((2S)-1,6-diamino-1-oxohexan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)amino)-4-oxobutanoic acid
- (S)-3-amino-4-((S)-1-((R)-1-((S)-1-((R)-1-((R)-1-((S)-1,6-diamino-1-oxohexan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-3-methyl-1-oxobutan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino)-3-(4-hydroxyphenyl)-1-oxopropan-2-ylamino)-4-oxobutanoic acid